欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
372	Benzalkonium chloride	HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO. LTD. Ezhou City CN	100049221;100083387	CEP 2024-096 - Rev 00	2025/04/30	Valid	30/04/2030	Chemical	2025/04/30	New application\|CEP granted\|30/04/2025
2932	Rivaroxaban	BAJAJ HEALTHCARE LIMITED Thane IN	100021782;100061986	CEP 2023-085 - Rev 00	2025/04/30	Valid	30/04/2030	Chemical	2025/04/30	New application\|CEP granted\|30/04/2025
1012	Famotidine	AZICO BIOPHORE INDIA PRIVATE LIMITED Hyderabad IN	100033325;100061652	CEP 2021-094 - Rev 02	2025/04/29	Valid	16/12/2027	Chemical	2025/04/29	Minor revision\|CEP granted\|29/04/2025; Notification\|CEP granted\|26/05/2023; New application\|CEP granted\|16/12/2022
1094	Cyproterone acetate, Micronised	FARMABIOS S.p.A Gropello Cairoli IT	100011643;100021232	CEP 2018-270 - Rev 01	2025/04/29	Valid		Chemical	2025/04/29	Renewal\|CEP granted\|29/04/2025
583	Lincomycin hydrochloride, Alternative process	XINYU PHARMACEUTICAL CO., LTD. Suzhou City CN	100020532;100056331	CEP 2020-105 - Rev 02	2025/04/29	Valid		Chemical	2025/04/29	Renewal\|CEP granted\|29/04/2025; Notification\|CEP granted\|28/02/2024; New application\|CEP granted\|10/07/2020
2416	Pramipexole dihydrochloride monohydrate	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	CEP 2010-328 - Rev 04	2025/04/29	Valid		Chemical	2025/04/29	Notification\|CEP granted\|29/04/2025; Minor revision\|CEP granted\|17/02/2023; Minor revision\|Accepted - CEP remains valid\|11/08/2021
2931	Sorafenib tosilate	SHANDONG LONCOM PHARMACEUTICAL CO., LTD Dezhou CN	100048642;100080616	CEP 2023-464 - Rev 00	2025/04/29	Valid	29/04/2030	Chemical	2025/04/29	New application\|CEP granted\|29/04/2025
1472	Sodium hyaluronate, GS-120, intrinsic viscosity: 1.7 m3/kg; from fermentation; for parenteral administration, including intra-ocular use	KIKKOMAN BIOCHEMIFA COMPANY Noda City JP	100039417;100087689	CEP 2023-034 - Rev 02	2025/04/29	Valid	21/06/2028	Chemical	2025/04/29	Minor revision\|CEP granted\|29/04/2025; Minor revision\|CEP granted\|30/04/2024; New application\|CEP granted\|21/06/2023
2577	Oxcarbazepine, Process-II	DASAMI LAB PRIVATE LIMITED Nalgonda IN	100033206;100051825	CEP 2023-348 - Rev 00	2025/04/29	Valid	29/04/2030	Chemical	2025/04/29	New application\|CEP granted\|29/04/2025
2930	Valganciclovir hydrochloride, Crystalline Type II	OLON S.P.A. Rodano IT	100012085;100019537	CEP 2023-217 - Rev 00	2025/04/29	Valid	29/04/2030	Chemical	2025/09/03	Minor revision\|Accepted - CEP remains valid\|03/09/2025; New application\|CEP granted\|29/04/2025
2733	Escitalopram oxalate, Process-IV	NEULAND LABORATORIES LIMITED Hyderabad IN	100011545;100062134	CEP 2025-005 - Rev 01	2025/04/29	Valid	05/03/2030	Chemical	2025/04/29	Minor revision\|CEP granted\|29/04/2025; New application\|CEP granted\|05/03/2025
2422	Oseltamivir phosphate, Form-A, route code OV	MSN LIFE SCIENCES PRIVATE LIMITED Chandampet Village IN	100018316;100027671	CEP 2024-571 - Rev 00	2025/04/29	Valid	29/04/2030	Chemical	2025/04/29	New application\|CEP granted\|29/04/2025
2209	Sulbactam sodium, Sterile	QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan CN	100033695;100052910	CEP 2024-030 - Rev 01	2025/04/29	Valid	14/03/2030	Chemical	2025/04/29	Administrative procedure\|CEP granted\|29/04/2025; New application\|CEP granted\|14/03/2025
645	Tobramycin, Spray-dried, amorphous	LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Fuzhou CN	100020920;100029633	CEP 2024-023 - Rev 01	2025/04/29	Valid	25/06/2029	Chemical	2026/01/22	Monograph revision\|Accepted - CEP remains valid\|22/01/2026; Notification\|CEP granted\|29/04/2025; New application\|CEP granted\|25/06/2024
1489	Ambroxol hydrochloride, Process II	AMI LIFESCIENCES PRIVATE LIMITED Karakhadi IN	100021822;100030527	CEP 2023-168 - Rev 01	2025/04/28	Valid	23/08/2028	Chemical	2025/04/28	Minor revision\|CEP granted\|28/04/2025; New application\|CEP granted\|23/08/2023
2127	Clobetasol propionate	CURIA SPAIN S.A.U. Boecillo ES	100011649;100019586	CEP 2011-095 - Rev 02	2025/04/28	Valid		Chemical	2025/04/28	Minor revision\|CEP granted\|28/04/2025; Notification\|CEP granted\|25/08/2021
2133	Troxerutin	TOPFOND PHARMACEUTICAL CO., LTD. Zhumadian CN	100023369;100077278	CEP 2023-419 - Rev 00	2025/04/28	Valid	28/04/2030	Chemical	2025/04/28	New application\|CEP granted\|28/04/2025
38	Levodopa	SHANDONG LUKANG PHARMACEUTICAL CO., LTD. Jining City CN	100025471;100071013	CEP 2022-202 - Rev 00	2025/04/28	Valid	28/04/2030	Chemical and TSE	2025/04/28	New application\|CEP granted\|28/04/2025
2600	Olmesartan medoxomil	CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN	100038839;100060978	CEP 2018-083 - Rev 04	2025/04/25	Valid		Chemical	2025/04/25	Renewal\|CEP granted\|25/04/2025; Minor revision\|CEP granted\|03/08/2023; Notification\|Accepted - CEP remains valid\|06/01/2023; Minor revision\|Accepted - CEP remains valid\|21/12/2022; Minor revision\|CEP granted\|06/09/2022; Monograph revision\|CEP granted\|06/05/2022
2017	Oxaliplatin, Process HER-2	HERAEUS PRECIOUS METALS GMBH & CO. KG Hanau DE	100012310;100021629	CEP 2006-137 - Rev 06	2025/04/25	Valid		Chemical	2025/04/25	Notification\|CEP granted\|25/04/2025; Notification\|CEP granted\|02/10/2023; Notification\|CEP granted\|18/07/2022; Notification\|CEP granted\|24/03/2021

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-